Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Explore the detailed record of transactions filed by M. Schaeffer, Director. Director active across 1 company, notably Vivoryon Therapeutics N.V.. Aggregated, 9 disclosures have been published. History available since 30 November 2020. The latest transaction was filed on 17 April 2026 (Purchase). Regulator: AFM. All data is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
9 of 9 declarations
M. Schaeffer is a board member of Vivoryon Therapeutics N.V., a company specializing in the development of therapeutic treatments. He contributes to the strategic direction of the company and oversees its operations. His expertise in the biopharmaceutical field is an asset for Vivoryon.